ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference

NEXT STORY
Vaccines & Drugs Industry: COVID-19 Implications, Market Assessment, Pipeline, Players and Outlook to 2025
PREV STORY
Local Company uses AI to Bring Screening to the Point of Care
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biosight Announces Initiation of Investigator Sponsored Phase 2 Clinical Trial of Aspacytarabine for Relapsed/Refractory AML and MDS with the Groupe Francophone des Myélodysplasies

author_avatar
NASDAQ Market News

New study will examine if inequities are contributing to an increased risk of COVID-19 within the Black Canadian population

author_avatar
NASDAQ Market News

Yamana Gold Announces Filing of Technical Reports for Canadian Malartic and El Peñón

author_avatar
NASDAQ Market News